The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Transdermal patches: history, development and pharmacology
Open accessAbstract
Transdermal patches are now widely used as cosmetic, topical and transdermal delivery systems. These patches represent a key outcome from the growth in skin science, technology and expertise developed through trial and error, clinical observation and evidence‐based studies that date back to the first existing human records. This review begins with the earliest topical therapies and traces topical delivery to the present‐day transdermal patches, describing along the way the initial trials, devices and drug delivery systems that underpin current transdermal patches and their actives. This is followed by consideration of the evolution in the various patch designs and their limitations as well as requirements for actives to be used for transdermal delivery. The properties of and issues associated with the use of currently marketed products, such as variability, safety and regulatory aspects, are then described. The review concludes by examining future prospects for transdermal patches and drug delivery systems, such as the combination of active delivery systems with patches, minimally invasive microneedle patches and cutaneous solutions, including metered‐dose systems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lane, M. E. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.040 · Cited by 1,486
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Scheuplein, R. J., & Blank, I. H. (1971) · Physiological Reviews · doi:10.1152/physrev.1971.51.4.702 · Cited by 1,398
Metabolism and Disposition Kinetics of Nicotine
Hukkanen, J., Jacob, P., & Benowitz, N. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.3 · Cited by 1,321
Nitric oxide in immunity and inflammation
Coleman, J. W. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(01)00086-8 · Cited by 945
Pawson, A. J., Sharman, J. L., Benson, H. E., Faccenda, E., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., Southan, C., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1143 · Cited by 849
Drug permeation through human skin: Theory and invitro experimental measurement
Michaels, A. S., Chandrasekaran, S. K., & Shaw, J. E. (1975) · AIChE Journal · doi:10.1002/aic.690210522 · Cited by 801
ACR guidance document on MR safe practices: 2013
Safety:, E. P. O. M., Kanal, E., Barkovich, A. J., Bell, C., Borgstede, J. P., Bradley, W. G., Froelich, J. W., Gimbel, J. R., Gosbee, J. W., Kuhni‐Kaminski, E., et al. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24011 · Cited by 761
The origins and evolution of “controlled” drug delivery systems
Hoffman, A. S. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.012 · Cited by 738
Transdermal drug delivery: overcoming the skin’s barrier function
Naik, A., Kalia, Y. N., & Guy, R. H. (2000) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(00)00295-9 · Cited by 720
Self-citation
Cited by
Enhancement strategies for transdermal drug delivery systems: current trends and applications
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00909-6 · Cited by 649
Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin
Prausnitz, M. R. (2017) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-060816-101514 · Cited by 439
Permeation enhancers in transdermal drug delivery: benefits and limitations
Kováčik, A., Kopečná, M., & Vávrová, K. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1713087 · Cited by 369
Current Biomedical Applications of 3D Printing and Additive Manufacturing
Ahangar, P., Cooke, M. E., Weber, M. H., & Rosenzweig, D. H. (2019) · Applied Sciences · doi:10.3390/app9081713 · Cited by 309
Topical and Transdermal Drug Delivery: From Simple Potions to Smart Technologies
Benson, H. A. E., Grice, J. E., Mohammed, Y., Namjoshi, S., & Roberts, M. S. (2019) · Current Drug Delivery · doi:10.2174/1567201816666190201143457 · Cited by 303
Self-citationMayer, M., & Baeumner, A. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00719 · Cited by 300
A Comprehensive Map of FDA-Approved Pharmaceutical Products
Zhong, H., Chan, G., Hu, Y., Hu, H., & Ouyang, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040263 · Cited by 288
3D printing applications for transdermal drug delivery
Economidou, S. N., Lamprou, D. A., & Douroumis, D. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.031 · Cited by 270
Vaccination into the Dermal Compartment: Techniques, Challenges, and Prospects
Hettinga, J., & Carlisle, R. (2020) · Vaccines · doi:10.3390/vaccines8030534 · Cited by 72
Novel Therapy for Male Hypogonadism
Carrasquillo, R., Chu, K., & Ramasamy, R. (2018) · Current Urology Reports · doi:10.1007/s11934-018-0816-x · Cited by 31
Skin models of cutaneous toxicity, transdermal transport and wound repair
Vilela de Sousa, I., Ferreira, M. J. S., Bebiano, L. B., Simões, S., Matos, A. F., Pereira, R. F., & Granja, P. L. (2023) · Burns & Trauma · doi:10.1093/burnst/tkad014 · Cited by 17
Metadata
- Authors
- Pastore, M. N., Kalia, Y. N., Horstmann, M., & Roberts, M. S.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2015-03-18
- Volume
- 172
- Issue
- 9
- Pages
- 2179-2209
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2157286284
- Cited by
- 586
- References
- 130
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.